Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
EFTR

EFTR - eFFECTOR Therapeutics, Inc. Stock Price, Fair Value and News

00
Market Closed

Price Targets

EFTR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EFTR Price Action

EFTR RSI Chart

EFTR Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

EFTR Valuation

EFTR Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

EFTR Fundamentals

EFTR Revenue

EFTR Earnings

EFTR Profitability

EFTR Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202202.5M3.6M3.9M
2021028.5M15.0M1.4M
202000042.0M
Get all data in R, Python etc through our Historical Stock Data APIs

About eFFECTOR Therapeutics, Inc.

EFTR
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.
 CEO
 WEBSITEhttps://effector.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES15

eFFECTOR Therapeutics, Inc. Frequently Asked Questions

EFTR is the stock ticker symbol of eFFECTOR Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

You can check EFTR's fair value in chart for subscribers.

The fair value guage provides a quick view whether EFTR is over valued or under valued. Whether eFFECTOR Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact eFFECTOR Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for EFTR.